Moldova’s Medicines & Medical Devices Agency Invites Indian Cos To Register & Export 141 Life-Saving Medicines

Mumbai: The Medicines and Medical Devices Agency from the Republic of Moldova has invited Indian pharma companies to register and export 141 pharmaceutical products for the treatment of chronic ailments like TB, HIV, hypertension, cardiac disorders and mental disorders, among others.

The Medicines and Medical Devices Agency is responsible for the registration of medical products in Moldova.

Medicines include phenylephrinum for cough related allergies, dobutamine for the treatment of cardiogenic shock and severe heart failure, argininum+sorbitolum to treat hypertension, tenofoviri disoproxili fumaras+lamivudinum+ dolutegravirum for the treatment of HIV, amoxicillinum+acidum clavulanic for the treatment of bacterial infections, tenofovir alafenamide for the treatment of hepatitis B infection, morphinum which is used as an analgesic, rifapentinum+isoniazidum to treat latent TB infection, linezolidum, which is an antibiotic used for the treatment of infections caused by gram-positive bacteria that are resistant to other antibiotics, antipsychotic medication haloperidolum, methylphenidate for treating attention deficit hyperactivity disorder (ADHD) in children and lamivudinum used to prevent and treat HIV/AIDS among others.

“We would like to bring to the notice of member companies that The Pharmaceuticals Export Promotion Council of India (Pharmexcil) is in receipt of communication from the Department of Pharmaceuticals (DoP) that the Republic of Moldova has shared a list of 141 pharmaceutical products required by Moldova. Member companies are requested to go through the list and share their willingness to supply the medicines preferably by November 10, 2023, to enable Council to share the list with the DoP and the Embassy of the Republic of Moldova to the Republic of India,” informed Uday Bhaskar, director general (DG), Pharmexcil.

“The proposal of Moldova is to initially identify Indian pharmaceutical exporters who are keen to explore this opportunity. Following that, the Medicines and Medical Devices Agency will get involved regarding regulatory and quality certification requirements,” Bhaskar further added.

The Republic of Moldova is a lower-middle-income country in Eastern Europe. The country was part of the former Soviet Union, from which it obtained independence in 1991. Since independence, Moldova, including its health sector, has undergone profound social, political and economic transformations. While some reforms were introduced in the hospital sector, much remains to be done and the most important changes so far were compelled by the introduction of a mandatory health insurance system in 2004. These included strengthening of primary health care and ensuring access to a limited number of medicines in privatised pharmacies and selected national programmes e.g. insulin, rare diseases, tuberculosis (TB), HIV/AIDS, immunisation.

Pharmaceutical sales in Moldova will grow over our extended forecast period, driven by increasing demand and improving access to medicines. While the generics segment will remain the dominant option, patented medicines will edge higher in terms of market share by 2032.

Related Posts

  • Pharma
  • May 30, 2024
  • 59 views
BRICS Vaccine Research Center Launched In India

New Delhi: In a statement issued after the meeting, Union Health Secretary Apurva Chandra said that the BRICS Vaccine Research and Development Centre, established during India’s BRICS presidency, was dedicated to…

  • Pharma
  • May 29, 2024
  • 59 views
DCA seizes ayurvedic syrup over false claims

Hyderabad: The Drugs Control Administration (DCA) Telangana conducted raids on shops selling products with misleading advertisements and seized an ayurvedic medicine in Kothur village. The medicine labelled as ‘stone crush…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

BRICS Vaccine Research Center Launched In India

BRICS Vaccine Research Center Launched In India

DCA seizes ayurvedic syrup over false claims

DCA seizes ayurvedic syrup over false claims

Delhi Police Busts Major Illegal Alprazolam Manufacturing Racket

Delhi Police Busts Major Illegal Alprazolam Manufacturing Racket

Ajooni Biotech expects additional revenue of Rs 200 crore from commercial production of Moringa by FY 25-26

Ajooni Biotech expects additional revenue of Rs 200 crore from commercial production of Moringa by FY 25-26

BackBack Natco Pharma share price rises 8% to 52 week high post Q4 results

BackBack Natco Pharma share price rises 8% to 52 week high post Q4 results

Human Milk Siphoned Off From Banks To Industries

Human Milk Siphoned Off From Banks To Industries